Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513572 · ClinicalTrials.gov registry record
Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices
A clinical trial, sponsored by Rhaeos.
- Terminated
- Registry status
- 10
- Enrollment target
NCT06513572 is a clinical trial that was terminated before completion, run by Rhaeos. The registered enrollment target is 10 participants.
The verdict
NCT06513572 was terminated before completion, sponsored by Rhaeos.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study collects data using non-invasive devices for assessing CSF shunt flow using thermal anisotropy measurements in a prospective study setting. The study will collect data to compare measurements from flowing shunts, non-flowing shunts, and off-shunt locations.
Interventions
- DEVICE FlowSense
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2024-07-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06513572
The ClinicalTrials.gov registry entry for NCT06513572 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhaeos, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FlowSense is the first listed.
NCT06513572 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06513572 about?
NCT06513572 is a clinical study titled "Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices". This study collects data using non-invasive devices for assessing CSF shunt flow using thermal anisotropy measurements in a prospective study setting. The study will collect data to compare measurements from flowing shunts, non-flowing shunts, and off-shunt locations.
What is the current status of trial NCT06513572?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2024-07-25. Estimated completion is 2024-07-27.
What interventions are being tested in trial NCT06513572?
The interventions under investigation include: FlowSense (DEVICE).
Who is sponsoring clinical trial NCT06513572?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.